← Back to headlines
Eli Lilly to Acquire Centessa Pharmaceuticals in $7.8 Billion Deal
Eli Lilly (LLY) has announced its intention to acquire Centessa Pharmaceuticals in a deal valued at $7.8 billion.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
